MRVI Stock Analysis: Buy, Sell, or Hold?
MRVI - Maravai LifeSciences Holdings, Inc. Class A Common Stock
$3.59
0.02 (0.70%)
▲
5d:
-2.85%
30d:
+24.48%
90d:
+4.82%
BUY
MODERATE Confidence
Analysis Updated: Apr 28, 2026 12:00 AM ET
Earnings: May 07, 2026
7d
Get Alerted When MRVI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: MRVI shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: MRVI shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: MRVI is currently trading at $3.58, which is considered extended relative to its 30-day fair value range of $2.91 to $3.47.
Technical Outlook: Technically, MRVI is in a downtrend. Immediate support is located at $3.26, while resistance sits at $3.81.
Market Sentiment: MRVI has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $4.60 (+29.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, MRVI is in a downtrend. Immediate support is located at $3.26, while resistance sits at $3.81.
Market Sentiment: MRVI has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $4.60 (+29.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$2.91 -
$3.47
Company Quality Score
60/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
63.2%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 29.2% below Wall St target ($4.60)
Trading Range Analysis
30-Day Trading Range
$2.91 -
$3.47
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$3.26
Resistance Level
$3.81
Current Trend
Downtrend
Technical data as of
Apr 28, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-23.45
Wall Street Target
$4.60
(+29.2%)
Revenue Growth (YoY)
-11.8%
Earnings Growth (YoY)
-32.7%
Profit Margin
-70.4%
Share & Embed Analysis
Last updated: April 29, 2026 11:00 AM ET
Data refreshes hourly during market hours. Next update: 12:00 PM
Data refreshes hourly during market hours. Next update: 12:00 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MRVI showing a specific setup today?
Insider Activity (6 Months)
5
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Gregory T Lucier
BUY
48528 shares
2025-12-08
Gregory T Lucier
BUY
51472 shares
2025-12-05
Bernd Brust
BUY
216212 shares
2025-11-13
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$27 | 57 HOLD |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$131 | 55 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$101 | 53 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$107 | 50 HOLD |
